NHS Branded Medicines Tranche Framework for London and South of England

Award

Buyers

Value

£39

Suppliers

Classifications

  • Pharmaceutical products

Tags

  • award
  • contract

Published

4 months ago

Description

NHS Branded Medicines Tranche Framework for London and South of England - 1 September 2024<br/>Offer reference number: CM/PHR/22/5689<br/>CM/PHR/22/5689/01 - NHS Framework for Branded Medicines - London & South of England Tranche A. Period of framework: 1 September 2024 to 31 August 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.<br/>CM/PHR/22/5689/02 - NHS Framework for Branded Medicines - London & South of England Tranche B. Period of framework: 1 September 2024 to 31 August 2026 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.<br/>CM/PHR/22/5689/03 - NHS Framework for the supply of Omalizumab and Diroximel Fumarate for the Midlands & East and North of England. Period of framework: 1 September 2024 to 31 August 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.

Documents

Premium

Bypass the hassle of outdated portals. Get all the information you need right here, right now.

  • Contract Agreement

    The official contract terms, conditions, and scopes of work.

    Download

  • Award Notice

    Details on the tender award and selected suppliers.

    Download

Similar Contracts

Open

NHS National Framework - Generics Housekeeping/Supply Chain Resilience Products

Project title: NHS National Framework for the supply of Generics Housekeeping / Supply Chain Resilience Products, commencing 1 June 2025 Offer reference number: CM/PHG/24/5720 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) for a period or periods up to a total of 48 months. Potential periods of call-offs under the framework agreement: CM/PHG/24/5720/01 - Orals (plus non-parenteral) Products CESW: (Midlands and Southwest): 1st June 2025 to 31st May 2027 (24 months) NWLN: (Northwest and London North): 1st June 2025 to 31st May 2027 (24 months) LSNE: (London South and Northeast): 1st June 2025 to 31st May 2027 (24 months) CM/PHG/24/5720/02 - Hospital Only Products DCE (Midlands) & DSW (Southwest): 1st June 2025 to 31st May 2026 (12 months) DNW (Northwest) & DLN (London North): 1st June 2025 to 31st January 2027 (20 months) DLS (London South) & DNE (Northeast): 1st June 2025 to 31st May 2026 (12 months) Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England Additional information: To express interest and participate in the tender, please register and apply via Atamis e-sourcing portal https://health-family.force.com/s/Welcome. Should Tenderers have any queries, or having problems using the portal, they should contact Helpdesk at: Phone: 0800 9956035 E-mail: [email protected]

NHS England

NHS England

Published 3 days ago
Open

NHS National Framework for the supply of Generics Housekeeping / Supply Chain Resilience Products, commencing 1 June 2025

Project title: NHS National Framework for the supply of Generics Housekeeping / Supply Chain Resilience Products, commencing 1 June 2025<br/><br/>Offer reference number: CM/PHG/24/5720<br/><br/>Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) for a period or periods up to a total of 48 months. <br/><br/>Potential periods of call-offs under the framework agreement:<br/>CM/PHG/24/5720/01 – Orals (plus non-parenteral) Products<br/>CESW: (Midlands and Southwest): 1st June 2025 to 31st May 2027 (24 months)<br/>NWLN: (Northwest and London North): 1st June 2025 to 31st May 2027 (24 months)<br/>LSNE: (London South and Northeast): 1st June 2025 to 31st May 2027 (24 months)<br/><br/>CM/PHG/24/5720/02 – Hospital Only Products<br/>DCE (Midlands) & DSW (Southwest): 1st June 2025 to 31st May 2026 (12 months)<br/>DNW (Northwest) & DLN (London North): 1st June 2025 to 31st January 2027 (20 months)<br/>DLS (London South) & DNE (Northeast): 1st June 2025 to 31st May 2026 (12 months)<br/><br/>Published By: Medicines Procurement and Supply Chain – NHS Medicines Value & Access, NHS England

NHS England

NHS England

Published 3 days ago
Open

NP47825 Multiple Sclerosis Medicines

Supply of multiple sclerosis medicines to NHS Scotland.

The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)

The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)

Published 1 week ago

AI Bid Assistant

Our AI-powered tool to help you create winning bids is coming soon!

View Contract Source Save Contract

Organisation

NHS England

Body governed by public law

+49 0800854430

+49 07887537432

Timeline complete

Publish
Bid
Evaluate
Award
Complete